Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sex differences in incidence and mortality of bloodstream infections. Results from the population-based HUNT study in Norway

View ORCID ProfileRandi Marie Mohus, View ORCID ProfileLise T. Gustad, View ORCID ProfileAnne Sofie Furberg, View ORCID ProfileMartine Kjølberg Moen, View ORCID ProfileKristin Vardheim Liyanarachi, View ORCID ProfileÅsa Askim, Signe E. Åsberg, View ORCID ProfileAndrew T. DeWan, View ORCID ProfileTormod Rogne, View ORCID ProfileGunnar Skov Simonsen, View ORCID ProfileTom Ivar Lund Nilsen, View ORCID ProfileBjørn Olav Åsvold, View ORCID ProfileJan Kristian Damås, View ORCID ProfileErik Solligård
doi: https://doi.org/10.1101/2021.08.24.21262516
Randi Marie Mohus
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Randi Marie Mohus
  • For correspondence: randi.m.mohus@ntnu.no
Lise T. Gustad
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
3Nord-Trøndelag Hospital Trust, Levanger, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lise T. Gustad
Anne Sofie Furberg
4Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway
5Faculty of Health and Social Sciences, Molde University College, Molde, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne Sofie Furberg
Martine Kjølberg Moen
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martine Kjølberg Moen
Kristin Vardheim Liyanarachi
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
6Department of Infectious Diseases, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristin Vardheim Liyanarachi
Åsa Askim
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Åsa Askim
Signe E. Åsberg
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew T. DeWan
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
7Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew T. DeWan
Tormod Rogne
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
7Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tormod Rogne
Gunnar Skov Simonsen
4Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway
8Research Group for Host-Microbe Interaction, Faculty of Health Sciences, UiT – The Arctic University of Norway, Tromsø, Norway
9Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gunnar Skov Simonsen
Tom Ivar Lund Nilsen
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
10Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tom Ivar Lund Nilsen
Bjørn Olav Åsvold
11K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
12Department of Endocrinology, Clinic of Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bjørn Olav Åsvold
Jan Kristian Damås
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
6Department of Infectious Diseases, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
13Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Kristian Damås
Erik Solligård
1Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Clinic of Anesthesia and Intensive Care, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik Solligård
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To examine the effect of sex on risk of bloodstream infections (BSI) and BSI mortality and to assess to what extent known risk factors for BSI mediate this association in the general population.

Participants The prospective, population-based HUNT2 Survey (1995-97) in Norway invited 93,898 inhabitants ≥20 years in the Nord-Trøndelag region, whereof 65,237 (69.5%) participated. 46.8% of the participants were men.

Exposures Sex and potential mediators between sex and BSI; health behaviours (smoking, alcohol consumption), education attainment, cardiovascular risk factors (systolic blood pressure, non-HDL cholesterol, body mass index) and previous or current comorbidities.

Main outcome measures Sex differences in risk of first-time BSI, BSI mortality (death within first 30 days after a BSI), BSI caused by the most frequent bacteria, and the impact of known BSI risk factors as mediators.

Results We documented a first-time BSI for 1,840 (2.9%) participants (51.3% men) during a median follow-up of 14.8 years. Of these, 396 (0.6%) died (56.6% men). Men had 41% higher risk of any first-time BSI (95% confidence interval (CI), 28 to 54%) than women. An estimated 34% of the excess risk of BSI in men was mediated by known BSI risk factors. The hazard ratio (HR) with 95% CI for BSI due to S. aureus was 2.09 (1.28 to 2.54), S. pneumoniae 1.36 (1.05 to 1.76), and E. coli 0.97 (0.84 to 1.13) in men vs women. BSI related mortality was higher in men compared to women with HR 1.87 (1.53 to 2.28).

Conclusions This large population-based study show that men have higher risk of BSI than women. One-third of this effect was mediated by known risk factors for BSI. This raises important questions regarding sex specific approaches to reduce the burden of BSI.

Introduction

Bloodstream infection (BSI) is a major global burden (1) and may lead to sepsis which constitutes up to 60% of the global mortality burden (2–4). The risk of acquiring BSI depends on the bacterial virulence, host characteristics and biological factors (5–9). Epidemiological studies indicate a male predominance in sepsis, nevertheless former studies on sex differences in incidence and mortality of sepsis have given conflicting results (2, 10–14). Importantly, disparities in immune function between sexes arise from differences in biological characteristics such as anatomy and hormonal status, medical conditions, health behaviours, lifestyle, and exposure to different pathogens (12, 15–17). Most previous studies on sex differences in BSI and sepsis have been performed in small cohorts, mainly from the intensive care unit (ICU), and there are limited population-based studies (12–14, 18, 19). Studies on severe infections and sepsis tend to adjust for sex in their analyses (20) without focusing on the mechanisms between sex and infection risk (21).

To assess the impact of sex as a risk factor for BSI we used data from the Norwegian HUNT Study linked with hospital-confirmed clinically relevant BSI to estimate the sex specific risk of any first-time BSI, BSI-related mortality, and first-time BSI caused by the most common infecting bacteria, Staphylococcus (S.) aureus, Streptococcus (S.) pneumoniae and Escherichia (E.) coli. Further, we aimed to investigate the potential mediating effect of health behaviours, education attainment, cardiovascular risk factors and comorbidities on the associations between sex and BSI.

Methods

Study population

The HUNT Study is a large-scale population-based health study conducted in mid-Norway and consists of four consecutive surveys inviting the total adult population approximately every 10th year. The second survey (HUNT2, 1995-97) invited all adult inhabitants ≥20 years (n=93,898) to a clinical examination, non-fasting blood sampling and a comprehensive self-report of health-related topics. Of these, 65,237 (69%) chose to participate. The HUNT study database is regularly updated with information on date of migration and death from the National Registry. More details on the HUNT study are published elsewhere (22). For the purpose of the present study, we excluded 47 (0.07%) participants who had a prior positive blood culture and 1,150 (1.8%) who migrated or died before start of follow-up. A total of 64,040 participants were eligible for analyses (Supplemental Figure 1 Flow-chart).

Measures

The exposure is sex as registered in the National Registry. The two main outcomes were first-time BSI and BSI related mortality. All BSIs were confirmed at the microbiology laboratories at Levanger, Namsos or at St. Olavs hospitals. The participants were followed-up for incident BSI by a linkage to the Nord-Trøndelag Hospital Trust (HNT HF) sepsis registry using the personal identification number of Norwegian citizens (23). We defined BSI mortality as death occurring within 30 days after detection of any BSI. In secondary analyses we assessed first-time BSI caused by the most common bacteria E. coli, S. aureus and S. pneumonia. Blood cultures solely with microorganisms associated with skin contamination such as coagulase negative Staphylococcus species, Corynebacterium species and Cutibacterium species were not considered as BSI (24).

Mediators are variables that are causally located between exposure and outcome variables, and that partly explain the effect of exposure on outcome (25). We used three distinct sets of mediators measured at inclusion; 1) health behaviours (smoking and alcohol use) and educational attainment; 2) cardiovascular risk factors (body mass index (BMI, kg/m2), systolic blood pressure (mmHg) and non-high-density lipoprotein cholesterol (non-HDL, mmol/L); 3) comorbidities defined by self-report of cardiovascular disease (history of myocardial infarction, angina pectoris, and/or stroke), diabetes, cancer history, lung disease (asthma or chronic obstructive pulmonary disease) and standardised measurements of kidney disease (estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2) (22). The three sets of mediators reflect known risk factors for BSI. Details about the measurements and categorisation of mediators are included in the supplemental material.

Statistical analyses

We used Cox proportional hazard regression analysis to estimate the hazard ratios (HRs) with 95% confidence intervals (CIs) of a first-time BSI and BSI mortality in men compared to women. Attained age was used as the time scale. Start of follow-up was defined by the availability of data in the sepsis registry. For residents belonging to Levanger hospital from 1 January 1995, and for residents belonging to Namsos hospital from 1 September 1999. Patients referred to St. Olavs hospital, the tertiary referral centre, BSI information was included depending on their primary hospital. Participants contributed person-years from inclusion date in HUNT2 except for participants having Namsos as their primary hospital, they entered the HNT HF sepsis registry from 1 September 1999. Data from all hospitals were available through 2011 (23).

In the analysis of BSI risk, participants were followed until their first BSI, for BSI-mortality participants were followed until death within 30 days of any BSI episode, and for both analyses participants were followed until migration out of Nord-Trøndelag, death of all causes or end of follow-up set to 31 December 2011, whichever occurred first. The proportional hazards assumption was examined by visual inspection of log-log plots and tests of Schoenfeld residuals. Using Stata stcompadj, we estimated cumulative incidence and mortality from start of follow-up to first-time BSI and BSI mortality, accounting for death by all causes as a competing risk.

In secondary analyses we estimated HRs and cumulative incidence of first-time BSI caused by the most common infecting bacteria; E. coli, S. aureus and S. pneumoniae using Cox regression and cumulative incidence. To address whether menopause affects women’s risk of BSI we conducted a sensitivity analysis stratified by age below and above 50 years.

The proportion of excess risk of BSI in men mediated by known BSI risk factors was estimated using an inverse odds weighting (IOW) procedure (26, 27). IOW is a counterfactual method that enables a decomposition of the total effect of the exposure (sex) on the outcome (first-time BSI) into a natural direct effect (NDE) from exposure on outcome, and a natural indirect effect (NIE) through multiple mediators jointly fitted in the model (25, 26). The method is robust to unmeasured common causes of the mediators (25).

The inverse odds weights were obtained by regressing the exposure (sex) on all mediators of interest with age as a covariate. In our analysis, the total effect is best interpreted as the total association between exposure (sex) and outcome (first-time BSI), the natural indirect effect is the proportion of excess BSI risk in men mediated by conventional BSI risk factors, whereas the natural direct effect is the proportion of excess BSI risk in men not associated with these factors. The proportion mediated is the percent of the total association that is mediated through the conventional risk factors. A graphic description of the mediation analyses is given in Figure 1. We did not estimate the NIE of individual mediators separately as it may not be appropriate when the mediators affect each other or when single mediator-outcome confounders may be affected by exposure (25). Instead, we estimated the NIE with a sequential mediation approach using three models. This approach assumes that the cardiovascular risk factors and further the comorbidities can be causal descendants of the health behaviours and educational attainment (25, 28). In model 1, we assessed health behaviours and education; in model 2, we added BMI, systolic blood pressure and non-HDL cholesterol; and in model 3, comorbidities were included to the complete set of mediators. The sequential approach further implies that model 3 reflects the best interpretation of the mediation analyses as all mediators and age are included (25).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Mediation analysis

Diagram of the direct and indirect (i.e. mediated) effects of sex on bloodstream infection. The green arrow represents the natural direct effect of the association. Red arrows represent model 1, proportion mediated by health behaviours and education attainment. Yellow arrows represent model 2, proportion mediated jointly by health behaviours, education, and cardiovascular risk factors. Blue arrows represent model 3, proportion mediated jointly by health behaviours, education, cardiovascular risk factors and comorbidities.

Model 1) Smoking, alcohol use and educational attainment at baseline.

Model 2) Systolic blood pressure, non-high-density lipoprotein cholesterol and Body Mass index.

Model 3) Cardiovascular disease, chronic kidney disease, diabetes, history of cancer, and chronic lung disease.

We performed bootstrapping based on 1,000 replications to derive percentile-based CIs for all mediation parameters (28). We present the NDE and NIE as HRs with 95 % CIs. The proportion mediated on the log scale was calculated using the formula (lnHRNIE /lnHRTOTAL) (26). All statistical analyses were performed using Stata version 16.0. A detailed description of the steps in the IOW analyses is included in supplemental material.

Ethics

The study was approved by the Regional Committee for Medical and Health Research Ethics of Central Norway (REK no 2012/153 and REK no 94135), and by the HUNT data access committee. Participation in HUNT2 was voluntary, and participants signed a written consent to data collection and linking their data to other registers.

Results

Population characteristics

Among 64,040 participants, of whom 46.8% were men, 1,840 (2.9%) experienced a BSI and 396 (0.6%) died within 30 days after an episode of BSI. The median age at inclusion was similar for both sexes. 51.3% of first-time BSI cases were men, and 56.6% of BSI-related deaths occurred in men (Table 1). Both men and women who experienced a BSI were older (median age at inclusion 67.4 and 68.0 respectively), and they had a higher comorbidity burden than participants who did not have a BSI during follow-up.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1: Baseline characteristics of the study population at inclusion in HUNT2, n=64,040

Risks of BSI and BSI mortality

Men were more likely to experience a first-time BSI and to die from a BSI compared to women. After adjustments for age, men had 1.41 (HR, 95% CI 1.28-1.54) higher risk of first-time BSI, and 1.87 (HR, 95% CI 1.53 – 2.28) higher risk of dying from a BSI within 30 days (Table 2). In analyses by the most common infecting bacteria compared to women, men had a 2.09-fold (HR, 95% CI 1.28 to 2.54) increased risk of BSI caused by S. aureus, and 1.36 (HR, 95% CI 1.05 to 1.76) increased risk of S. pneumonia. The corresponding result for E. coli did not show higher risk in men with HR of 0.97 (95% CI 0.84 to 1.13) (Table 3).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2. Associations of sex with risk of bloodstream infection and BSI mortality
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3. Associations of sex with risk of bloodstream infections caused by the most common bacteria

Figure 2 illustrates the above findings by graphing the age-adjusted cumulative incidence of first-time BSI and cumulative BSI mortality. The cumulative incidence of BSI was higher among men than women after the first five years of follow-up. For BSI mortality the sex difference was apparent after the first 2.5 years of follow-up and during follow-up the sex differences in mortality increases substantially. We present cumulative incidence curves for the three most common infecting bacteria in Figure 3A, B and C. Men had higher incidence of S. aureus, especially after the first 7 years of follow-up, whereas E. coli had higher cumulative incidence among women.

Figure 2:
  • Download figure
  • Open in new tab
Figure 2: Sex differences in cumulative incidence and mortality of BSI

Age-adjusted sex difference in cumulative incidence of BSI (A), and in cumulative mortality (B), estimated for age 49.99 (the mean age of the total population). Note: due to the variation in incidence of different outcomes the scale of the Y-axis is not uniform across the panels.

Figure 3:
  • Download figure
  • Open in new tab
Figure 3: Sex differences in cumulative incidence of BSI caused by the most common bacteria

Age-adjusted sex difference in cumulative incidence of S. aureus (A), S. pneumoniae (B), and E. coli (C), estimated for age 49.99 (the mean age of the total population). Note: due to the variation in incidence of different bacteria the scale of the Y-axis is not uniform across the panels.

The age-stratified analyses at estimated menopause (≤50 years) did not reveal any clear sex difference in risk of BSI before menopause. However, the youngest age-group had few episodes of BSI, and few persons died from a BSI (Supplemental Table 1).

Mediation analyses

In Table 4 we present the total effect, the natural direct and indirect effects of sex on risk of first-time BSI. Compared with women men had an estimated HR of 1.40 (95% CI 1.24 to 1.55) for first-time BSI. Behavioural risk factors and education mediated 10% of the total effect (model 1), adding the cardiovascular risk factors mediated 5% (model 2), whereas the whole set of mediators, including comorbidities, jointly mediated 34% of the total effect (model 3). The mediation results indicate that male sex is a risk factor for BSI, but also that men with increased burden of conventional BSI risk factors are at particular risk.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4:

Mediation of the associations between sex and BSI by behavioral risk factors, educational attainment, cardiovascular risk factors and comorbidities.

Discussion

In this large Norwegian population-based study with a follow-up of more than 15 years, male sex was associated with 1.41 times higher risk of BSI and 1.87 times higher risk of dying from a BSI. An estimated 34% of the increased risk of BSI in men was mediated by conventional BSI risk factors. We additionally found that men had 2.09 times higher risk of BSI caused by S. aureus compared to women. Importantly, our findings indicate that male sex contributes as an individual and important risk factor for BSI. However, they do not refute the impact of baseline burden of health behaviours, education and pre-existing chronic health conditions in sex disparities seen in BSI.

Comparison with other studies

There are few population-based studies on sex differences in the epidemiology of BSI and to our knowledge, no previous mediation analysis has combined conventional risk factors with validated BSI events to examine this topic. The rich baseline information from HUNT2 including chronic medical conditions, cardiovascular risk factors, health behaviours and education attainment allowed us to investigate how these factors mediated the association between sex and BSI. We used the IOW approach which is known to be robust using multiple mediators en bloc, and allowed us to implement causal mediation analyses in a time-to-event context (25, 26). The sequential approach enabled us to examine the portion mediated through health behaviours and education, which accounted for 10 %. Adding cardiovascular risk factors the proportion mediated accounted for 5%, indicating some interactions or common pathways for the mediators (25). The complete model accommodate the assumptions required, and most likely reflects the best modelling of the associations (25). In our analyses the proportion mediated by age and all mediators combined was 34%. Interventions to reduce modifiable risk factors in the population will likely reduce the burden of BSI, particularly in aging men with high burden of known risk factors. This is an important finding that deserves further investigations.

The population-based design ensures that all BSI occurring in residents of a defined geographical area are included, which is an advantage over ICU cohorts (29). Our results are supported by one population-based BSI study including 1,051 patients with positive blood cultures showing that men had higher risk of BSI. In particular they found that BSI incidence increases sharply by age, and men had twice the rate of S. aureus BSI (18). Another population-based study from Canada comprising 9,266 patients with BSI admitted to ICU found that male sex is a risk factor for BSI (19). From the same research group, a recent study restricted to persons aged ≥65, found that men were at increased risk compared to females (incidence rate ratio 1.44, 95% CI 1.32-1.59) and the sex difference was most pronounced in the oldest patients (30). On the other hand, the global burden of disease study found that age-standardised sepsis incidence was higher among women, while sepsis-related mortality was higher among men (2). This study included results from 195 countries and comprised all age groups. They found a substantially higher sepsis incidence in low-income countries, and the pattern of sepsis incidence and mortality varied according to location, which is not directly comparable to our study population.

We identified higher BSI mortality in men which is in line a population-based study of BSI in critically ill adults (31), and a recent study on infection related death in UKBiobank (32). Conversely, some ICU studies report higher sepsis-related mortality in women. A retrospective study with 18,757 adult ICU patients, found higher mortality in women (13). The same pattern was observed in a Swedish study on community acquired sepsis where women had 28% higher odds of dying (10), and in a smaller ICU cohort from Germany studying 709 adults (11). This conflicting evidence concerning sex differences in mortality is most likely due to the heterogeneity of BSI and sepsis depending on the aetiology and the cohort studied (29, 31), but may also be affected by sex differences in immune responses (15–17, 33) and differences in treatment (13, 34).

The second most common infecting agent in our study was S. aureus which was far more common in men. S. aureus is associated with superficial infections of soft tissues with the potential for severe invasive infections and is the most important cause of BSI-associated death (35, 36). Previous studies indicate higher probability of nasal colonization in men which is a major risk factor for invasive S. aureus infections (37). Other studies show that circulating levels of testosterone and use of hormone contraceptives among females alter nasal colonization indicating that sex hormones affect the immune response to S. aureus (38, 39). The substantially higher prevalence of S. aureus colonization in men is of particular interest, and preventive measures like eradication or temporary suppression could lower the risk of invasive infections (40), which is especially important in hospitalized patients.

In a sensitivity analysis we found that the sex differences in BSI risk are evident after predicted age of menopause indicating that alterations in both innate and adaptive immune functions with age may be sex specific. Aging is associated with chronic inflammation and a generally reduced immune function. Women face an abrupt decline during menopause, whereas men have a steady decline from second decade of life (41). As in former studies, our study points out that advancing age is a risk factor for developing and dying from BSI and elderly men are at particular risk (18, 19, 30).

Strengths and limitations of the study

Major strengths of our study include its large size, the population-based design, long-term follow-up and linkage to all microbiological records which represent the gold standard to identify BSI (29). Reviews of medical records of patients with S. aureus and S. pneumoniae BSI in this cohort showed that ∼98% met the 2001 sepsis criteria (35, 42). Our definition of BSI as a laboratory verified positive blood culture, excluding blood cultures solely with microorganisms associated with skin contamination, ascertains the accuracy of the outcome studied. We were able to study BSI incidence and BSI mortality in a large population without the potential referral bias seen in single institution studies of BSI. The complete ascertainment of all BSI allows for an accurate estimation of incidence and mortality in the population, with the potential of risk factor identification and mediation analyses.

There are some limitations of our study that merit attention. First, we lack information on immunosuppressive medication and use of statins before or at time of infection which are known risk factors for BSI and BSI mortality (9, 43). Second, investigating BSI is dependent on clinician’s suspicion and decision to submit blood cultures for testing, with the chance of some undetected cases. Further, we cannot rule out if the clinical presentation of infections is different in men and women and that this could result in disproportionate blood culture sampling depending on sex. Third, the mediators are only measured once at inclusion to HUNT2 and could have changed during the 15 years of follow-up. This potential misclassification would most likely be non-differential and lead to underestimation of the mediating effect (44). Another concern is the subjective assessment of some mediators, and dichotomised mediators are more prone to possible mediator misclassification. This could lead to underestimation of the indirect effect and overestimation of the direct effect (45).

Despite these limitations and to the best of our knowledge, we present the first large, epidemiological study elucidating sex differences in BSI. With a non-selected, homogenous population-based study with long follow-up on blood-culture verified BSI with known pathogen, our study contributes to a growing body of evidence that sex influence BSI risk.

Meaning of the study and future research

This study provides important information for clinicians, researchers and policymakers concerning BSIs. We show that sex disparities in BSI cannot be explained by comorbidity burden, health behaviours and educational level alone. The clinical implications of our findings largely depend on elucidation of the underlying mechanisms behind the observed sex differences.

Sex affects the shape of immune responses which is attributed to genetic, hormonal and environmental factors (15, 16, 33). The human X-chromosome encodes a number of critical genes involved in the regulation of immune functions (33). It is increasingly clear that sex extensively influences the host immune responses, but this sexual dimorphism is underappreciated, and sex bias is a major challenge in clinical trials (20, 34, 46). Sex hormones act as important modulators of immune functions and responses; testosterone and progesterone are immunosuppressive, while oestradiol is immunoenhancing (16). Few human studies have investigated sex hormones’ effects in sepsis. Interestingly, in covid-19 where men are more prone to a severe course, the use of antiandrogens in men have shown promising results on severity (47). Furthermore, in a review of health records in post-menopausal women with regular use of oestradiol, the fatality risk of covid-19 is reduced by more than 50% (48).

Future perspectives of our results include the need for targeted research on how these sex differences could be addressed to achieve a longer and healthier life for both men and women. Additional work should focus on how genetics and epigenetics as well as sex hormones play a role in the sex disparities seen in infectious diseases. Knowledge of mediating factors together with recognition of sex differences in severe infections are important for public health leaders, researchers and clinicians as it can inform preventive actions and identify individuals especially at risk (21, 49).

Conclusion

In this large population-based cohort, men had an increased risk of BSI and BSI mortality, where 34% risk of BSI was explained by known risk factors. BSI represents an important global burden of disease, and by establishing the presence of sex differences in BSI our study provides as a catalyst for additional investigations. This will advance our understanding of sex specific host-pathogen interactions and sex hormone’s immune actions, and potentially lead to targeted management strategies to prevent BSI and sepsis in both men and women.

Data Availability

The data used in this work is available by application from HUNT. https://hunt-db.medisin.ntnu.no/hunt-db/

Competing interests

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Funding

This work was supported by a grant from The Liaison Committee for education, research, and innovation in Central Norway.

Contribution

RMM, LG, MKM, KVL, SEÅ, TN, JKD and ES conceived and designed the study. TN, BOÅ, LG, ATD, TR, JKD and ES supervised the study. RMM, BOÅ, ÅA and LG contributed in the acquisition of data for statistical analyses. RMM analyzed the data, prepared tables and figures. RMM, LG, ASF, MKM, KVL, ÅS, SEÅ, GSS, TR, TN, ATD, BOÅ, ES and JKD interpreted the results and drafted the manuscript. RMM, LG, ASF, MKM, KVL, ÅA, SEÅ, ATD, TR, GSS, TN, BOÅ, JKD and ES contributed to the discussions and revised the manuscript critically for important intellectual content. All the authors have read and approved the final version of manuscript and agreed to be accountable for all aspects of the work.

Acknowledgements

The Trøndelag Health Study (the HUNT study) is a collaboration of the HUNT research center (Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology), Trøndelag County Council, Central Norway Regional Health Authority, and the Norwegian Institute of Public Health.

We sincerely thank Arne Mehl (1948-2021) for his extensive and thorough work with the HNT HF sepsis registry, the microbiology departments of Levanger, Namsos and St. Olav hospitals for providing microbial data, and the Department for Research at Nord-Trøndelag Hospital Trust for assistance with data linkage.

References

  1. 1.↵
    Goto M, Al-Hasan MN. (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19(6):501–9. https://doi.org/10.1111/1469-0691.12195
    OpenUrlCrossRefPubMed
  2. 2.↵
    Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. (2020) Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 395(10219):200–11. https://doi.org//10.1016/s0140-6736(19)32989-7
    OpenUrlCrossRefPubMed
  3. 3.
    Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 315(8):801–10. https://doi.org/10.1001/jama.2016.0287
    OpenUrlCrossRefPubMed
  4. 4.↵
    Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. (2016) Late mortality after sepsis:pensity matched cohort study. BMJ 353:i2375. https://doi.org/10.1136/bmj.i2375
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Reddick LE, Alto NM. (2014) Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol Cell 54(2):321–8. https://doi.org/10.1016/j.molcel.2014.03.010
    OpenUrlCrossRefPubMed
  6. 6.
    Paulsen J, Askim A, Mohus RM, Mehl A, Dewan A, Solligard E, et al. (2017) Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study. Int J Epidemiol 46(5):1573–81. https://doi.org/10.1093/ije/dyx091
    OpenUrlCrossRefPubMed
  7. 7.
    Mohus RM, Paulsen J, Gustad L, Askim Å, Mehl A, DeWan AT, et al. (2018) Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway. Intensive Care Med 44(8):1276–83. https://doi.org/10.1007/s00134-018-5320-8
    OpenUrl
  8. 8.
    Askim A, Gustad LT, Paulsen J, Reitan SK, Mehl A, Mohus RM, et al. (2018) Anxiety and Depression Symptoms in a General Population and Future Risk of Bloodstream Infection: The HUNT Study. Psychosom Med 80(7):673–9. https://doi.org/10.1097/psy.0000000000000619
    OpenUrlCrossRef
  9. 9.↵
    Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, et al. (2014) Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile. Chest 146: 1205–1213. https://doi.org/10.1378/chest.13-2618
    OpenUrlCrossRefPubMed
  10. 10.↵
    Sunden-Cullberg J, Nilsson A, Inghammar M, (2020) Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study. Intensive Care Medicine 46: 727–736. https://doi.org/10.1007/s00134-019-05910-9
    OpenUrl
  11. 11.↵
    Nachtigall I, Tafelski S, Rothbart A, Kaufner L, Schmidt M, Tamarkin A, et al. (2011) Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care 15(3):R151. https://doi.org/10.1186/cc10277
    OpenUrlCrossRefPubMed
  12. 12.↵
    Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. (2006) The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 34(10):2576–82. https://doi.org/10.1097/01.Ccm.0000239114.50519.0e
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Pietropaoli AP, Glance LG, Oakes D, Fisher SG. (2010) Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med 7(5):422–37. https://doi.org/.1016/j.genm.2010.09.005
    OpenUrlCrossRefPubMed
  14. 14.↵
    Adrie C, Azoulay E, Francais A, Clec’h C, Darques L, Schwebel C, et al. (2007) Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 132(6):1786–93. https://doi.org/10.1378/chest.07-0420
    OpenUrlCrossRefPubMed
  15. 15.↵
    Vázquez-Martínez ER, García-Gómez E, Camacho-Arroyo I, González-Pedrajo B. (2018) Sexual dimorphism in bacterial infections. Biol Sex Differ 9(1):27. https://doi.org/10.1186/s13293-018-0187-5
    OpenUrlCrossRef
  16. 16.↵
    Klein SL, Flanagan KL. (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626–38. https://doi.org/10.1038/nri.2016.90
    OpenUrlCrossRefPubMed
  17. 17.↵
    vom Steeg LG, Klein SL. (2016) SeXX Matters in Infectious Disease Pathogenesis. PLoS Pathog 12(2):e1005374. https://doi.org/.1371/journal.ppat.1005374
    OpenUrlCrossRefPubMed
  18. 18.↵
    Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, 3rd, St Sauver JL, Wilson WR, et al. (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167(8):834–9. https://doi.org/10.1001/archinte.167.8.834
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32(4):992–7. https://doi.org/10.1097/01.ccm.0000119424.31648.1e
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Shapiro JR, Klein SL, Morgan R. (2021) Stop ‘controlling’ for sex and gender in global health research. BMJ Glob Health 6(4). https://doi.org//10.1136/bmjgh-2021-005714
  21. 21.↵
    WHO. Addressing sex and gender in epidemic-prone infectious diseases (2007). Geneva: World Health Organization; https://apps.who.int/iris/handle/10665/43644 accessed 10 August 2021.
  22. 22.↵
    Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, et al. (2012) Cohort Profile: The HUNT Study, Norway. Int J Epidemiol 42(4):968–77. https://doi.org/10.1093/ije/dys095
    OpenUrlPubMedWeb of Science
  23. 23.↵
    Mehl A, Åsvold BO, Lydersen S, Paulsen J, Solligård E, Damås JK, et al. (2017) Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study. BMC Infect Dis 17(1):205. https://doi.org/10.1186/s12879-017-2291-2
    OpenUrl
  24. 24.↵
    Hall KK, Lyman JA. (2006) Updated review of blood culture contamination. Clin Microbiol Rev 19(4):788–802. https://doi.org/10.1128/cmr.00062-05
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    VanderWeele T, Vansteelandt S. (2014) Mediation Analysis with Multiple Mediators. Epidemiol Methods 2(1):95–115. https://doi.org/10.1515/em-2012-0010
    OpenUrl
  26. 26.↵
    Nguyen QC, Osypuk TL, Schmidt NM, Glymour MM, Tchetgen Tchetgen EJ. (2015) Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting. Am J Epidemiol 181(5):349–56. https://doi.org/10.1093/aje/kwu278
    OpenUrlCrossRefPubMed
  27. 27.↵
    Hossin MZ, Koupil I, Falkstedt D. Early life socioeconomic position and mortality from cardiovascular diseases: an application of causal mediation analysis in the Stockholm Public Health Cohort. BMJ Open. 2019;9(6):e026258. https://doi.org/10.1136/bmjopen-2018-026258
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Preacher KJ, Hayes AF. (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40(3):879–91. https://doi.org/10.3758/brm.40.3.879
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    Laupland KB. (2013) Defining the epidemiology of bloodstream infections: the ‘gold standard’ of population-based assessment. Epidemiol Infect 141(10):2149–57. https://doi.org/10.1017/s0950268812002725
    OpenUrlCrossRef
  30. 30.↵
    Laupland KB, Pasquill K, Steele L, Parfitt EC. (2021) Burden of bloodstream infection in older persons: a population-based study. BMC Geriatr 21(1):31. https://doi.org/10.1186/s12877-020-01984-z
    OpenUrl
  31. 31.↵
    Laupland KB, Davies HD, Church DL, Louie TJ, Dool JS, Zygun DA, et al. (2004) Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study. Infection 32(2):59–64. https://doi.org/10.1007/s15010-004-3064-6
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    Drozd M, Pujades-Rodriguez M, Lillie PJ, Straw S, Morgan AW, Kearney MT, et al. Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study. The Lancet Infectious Diseases. 2021;21(8):1184–91. https://doi.org/10.1016/S1473-3099(20)30978-6
    OpenUrl
  33. 33.↵
    Libert C, Dejager L, Pinheiro I. (2010) The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 10(8):594–604. https://doi.org/10.1038/nri2815
    OpenUrlCrossRefPubMed
  34. 34.↵
    Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. (2020) Sex and gender: modifiers of health, disease, and medicine. Lancet 396(10250):565–82. https://doi.org/10.1016/s0140-6736(20)31561-0
    OpenUrlCrossRefPubMed
  35. 35.↵
    Paulsen J, Mehl A, Askim A, Solligard E, Asvold BO, Damas JK. (2015) Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study. BMC Infect Dis 15:116. https://doi.org/10.1186/s12879-015-0849-4
    OpenUrlCrossRefPubMed
  36. 36.↵
    Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. (2013) The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 19(5):465–71. https://doi.org/10.1111/j.1469-0691.2012.03903.x
    OpenUrlCrossRefPubMed
  37. 37.↵
    Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O. (2018) Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front Microbiol 9:2419. https://doi.org/10.3389/fmicb.2018.02419
    OpenUrlCrossRef
  38. 38.↵
    Stensen DB, Småbrekke L, Olsen K, Grimnes G, Nielsen CS, Sollid JUE, et al. (2021) Circulating sex-steroids and Staphylococcus aureus nasal carriage in a general female population. Eur J Endocrinol 184(2):337–46. https://doi.org/10.1530/eje-20-0877
    OpenUrl
  39. 39.↵
    Stensen DB, Småbrekke L, Olsen K, Grimnes G, Nielsen CS, Simonsen GS, et al. (2019) Hormonal contraceptive use and Staphylococcus aureus nasal and throat carriage in a Norwegian youth population. PLOS ONE 14(7):e0218511. https://doi.org/10.1371/journal.pone.0218511
    OpenUrl
  40. 40.↵
    Liu Z, Norman G, Iheozor-Ejiofor Z, Wong JK, Crosbie EJ, Wilson P. (2017) Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers. Cochrane Database Syst Rev 5(5):Cd012462. https://doi.org/10.1002/14651858.CD012462.pub2
    OpenUrl
  41. 41.↵
    Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309–21. https://doi.org/10.1111/acel.12326
    OpenUrlCrossRefPubMed
  42. 42.↵
    Askim A, Mehl A, Paulsen J, DeWan AT, Vestrheim DF, Asvold BO, et al. (2016) Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study. BMC Infect Dis 16:223. https://doi.org/10.1186/s12879-016-1553-8
    OpenUrl
  43. 43.↵
    Mehl A, Harthug S, Lydersen S, Paulsen J, Åsvold BO, Solligård E, et al. (2015) Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study. Eur J Clin Microbiol Infect Dis 34(3):609–17. https://doi.org/10.1007/s10096-014-2269-6
    OpenUrlCrossRefPubMed
  44. 44.↵
    Rothman K. LT. Modern Epidemiology. 4th Ed. ed: Lippincott Williams & Wilkins (LWW); 2020.
  45. 45.↵
    Richiardi L, Bellocco R, Zugna D, (2013) Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol 42(5):1511–9. https://doi.org/10.1093/ije/dyt127
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    Wallach JD, Sullivan PG, Trepanowski JF, Steyerberg EW, Ioannidis JP. Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses. Bmj. 2016;355:i5826. https://doi.org/10.1136/bmj.i5826
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A, (2021) Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical). Cureus13(2):e13047. https://doi.org/10.7759/cureus.13047
    OpenUrl
  48. 48.↵
    Seeland U, Coluzzi F, Simmaco M, Mura C, Bourne PE, Heiland M, et al. (2020). Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med 18(1):369. https://doi.org/10.1186/s12916-020-01851-z
    OpenUrl
  49. 49.↵
    Evagora-Campbell M, Borkotoky K, Sharma S, Mbuthia M. From routine data collection to policy design: sex and gender both matter in COVID-19. The Lancet. 2021;397(10293):2447–9. https://doi.org/10.1016/S0140-6736(21)01326-X
    OpenUrl
Back to top
PreviousNext
Posted August 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sex differences in incidence and mortality of bloodstream infections. Results from the population-based HUNT study in Norway
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sex differences in incidence and mortality of bloodstream infections. Results from the population-based HUNT study in Norway
Randi Marie Mohus, Lise T. Gustad, Anne Sofie Furberg, Martine Kjølberg Moen, Kristin Vardheim Liyanarachi, Åsa Askim, Signe E. Åsberg, Andrew T. DeWan, Tormod Rogne, Gunnar Skov Simonsen, Tom Ivar Lund Nilsen, Bjørn Olav Åsvold, Jan Kristian Damås, Erik Solligård
medRxiv 2021.08.24.21262516; doi: https://doi.org/10.1101/2021.08.24.21262516
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Sex differences in incidence and mortality of bloodstream infections. Results from the population-based HUNT study in Norway
Randi Marie Mohus, Lise T. Gustad, Anne Sofie Furberg, Martine Kjølberg Moen, Kristin Vardheim Liyanarachi, Åsa Askim, Signe E. Åsberg, Andrew T. DeWan, Tormod Rogne, Gunnar Skov Simonsen, Tom Ivar Lund Nilsen, Bjørn Olav Åsvold, Jan Kristian Damås, Erik Solligård
medRxiv 2021.08.24.21262516; doi: https://doi.org/10.1101/2021.08.24.21262516

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1962)
  • Dentistry and Oral Medicine (253)
  • Dermatology (187)
  • Emergency Medicine (335)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (703)
  • Epidemiology (11123)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3196)
  • Geriatric Medicine (310)
  • Health Economics (567)
  • Health Informatics (2049)
  • Health Policy (864)
  • Health Systems and Quality Improvement (789)
  • Hematology (310)
  • HIV/AIDS (685)
  • Infectious Diseases (except HIV/AIDS) (12742)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (337)
  • Neurology (3004)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1561)
  • Ophthalmology (478)
  • Orthopedics (186)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (386)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2799)
  • Public and Global Health (5613)
  • Radiology and Imaging (1101)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (764)
  • Rheumatology (341)
  • Sexual and Reproductive Health (315)
  • Sports Medicine (289)
  • Surgery (348)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)